Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 3 4Phase 2 2

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Overweight 1Obesity 1Motor Activity 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Endometrial Neoplasms 1Disease 1Depressive Disorder 1Depression 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Counseling × Clear all
NCT01621659 2026-05-11

TITAN

University of Alberta

Phase 2 Active not recruiting
80 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT00712621 2009-11-24

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

American Scitech International

Phase 2 Withdrawn
460 enrolled
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡